from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1765c/-

LFCtreatmentdescriptionclass of inhibitor

-0.168

Amikacinug/mL Amikacintranslation

-0.299

Cap5-10ug/mL Capreomycintranslation

-0.445

Rox10-50 ug/mL Roxithromycintranslation

-0.233

SM2-5 ug/mL Streptomycintranslation

-0.202

Tet5-10 ug/mL Tetracyclinetranslation

-0.134

Rif0.2-5ug/mL Rifampicintranscription

-0.214

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.614

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.135

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.299

CPZ10-50 ug/mL Chlorpromazinerespiration

0.199

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.404

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.899

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.053

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.236

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.545

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.583

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.219

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.374

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.410

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.091

KCN5-20 ug/mL Potassium cyaniderespiration

-0.489

NaN30.2-2 mM Sodium aziderespiration

-0.236

Nigericin50 uM Nigericinrespiration

0.533

TRC10-150 ug/mL Triclosanrespiration

0.567

TRZ10-25 ug/mL Thioridazinerespiration

-0.088

Valinomycin0.5-10 uM Valinomycinrespiration

-0.929

ZnSO42 mM ZnSO4respiration

0.502

menadione6-10 ug/mL Menadionerespiration

-0.153

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.330

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.651

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.916

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.649

NRP_1Non-replicating persistence stage 1dosRassociated

-0.561

Amp0.2mg/mL AmpicillincellWall

-0.409

Cephalexin20-100 ug/mL CephalexincellWall

-0.565

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.462

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.542

EMB10-20 ug/mL EthambutolcellWall

-0.418

Eta12-40 ug/mL EthionamidecellWall

-0.582

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.407

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.966

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.832

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.195

BZA0.12 mg/mL BenzamidearomaticAmides

0.046

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.050

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.485

H2O24 mM hydrogen peroxideDNAdamaging

1.900

Levo10 ug/mL LevofloxacinDNAdamaging

0.202

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.528

Novobiocin10 ug/mL NovobiocinDNAdamaging

3.512

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.680

UVUV-irradiationDNAdamaging

0.360

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.567

Antimycin12.5-50 ug/mL Antimycin A?

-0.283

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.129

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.334

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.611

PA8240.2-2 ug/mL PA-824?

0.556

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.036

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.453

Verapamil50 uM Verapamil?

-0.339

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.879

methoxatin10-20 ug/mL Methoxatin?